Sodium Chloride
- Product NDC
- 63323-187
- 11-digit product format
- 633230187
- Labeler code
- 63323
- Product ID
- 63323-187_946d321a-eccd-5144-e053-2995a90afa2e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SODIUM CHLORIDE
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2000-09-05
- Marketing end
- 0000-00-00
- Substance
- SODIUM CHLORIDE
- Active strength
- 234 mg/mL
- Pharmacologic classes
- Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-187-30 | Sodium Chloride | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 30 | | 4 |
| 63323-187-30 | Sodium Chloride | 25 in 1 TRAY | INJECTION | 25 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | SODIUM CHLORIDE INJECTION [APP PHARMACEUTICALS, LLC] | 1 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | SODIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [GENERAL INJECTABLES & VACCINES, INC] | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | SODIUM CHLORIDE INJECTION [APP PHARMACEUTICALS, LLC] | 1 | |
| Sodium Cation | ACTIVE MOIETY | LYR4M0NH37 | SODIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [GENERAL INJECTABLES & VACCINES, INC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | SODIUM CHLORIDE INJECTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | SODIUM CHLORIDE INJECTION [APP PHARMACEUTICALS, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-187 | SODIUM CHLORIDE INJECTION [FRESENIUS KABI USA, LLC] | 3 | Legacy NDC, 2 package rows | 20241018_ea5d8afd-c986-4290-857f-15d86713f71e.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-187-30 | 63323018730 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-187-30) > 30 mL in 1 VIAL, SINGLE-DOSE | 2000-09-05 | 0000-00-00 | No | No | Current |